Streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis--second report. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
D000351:Africa, Eastern; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D006801:Humans; D008826:Microbial Sensitivity Tests; D010044:Outpatient Clinics, Hospital; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000009:adverse effects; D011859:Radiography; D013307:Streptomycin / Q000008:administration & dosage* / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D011718:Pyrazinamide; D013307:Streptomycin